Sherbrooke Park Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,956
Closed -$529K 1142
2024
Q3
$529K Buy
16,956
+1,424
+9% +$44.4K 0.12% 288
2024
Q2
$415K Buy
+15,532
New +$415K 0.07% 497